RT @sitcancer: #JITC Research: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of ex…
#JITC Research: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders https://t.co/vasRVZ50dT https://t.co/K6cHcm9Nrc
wonder MITF is included in the typical NGS panels
RT @sitcancer: #JITC Research: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of ex…
#JITC Research: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders https://t.co/vasRVZ50dT https://t.co/wCEpaq7deE
RT @sitcancer: #JITC Research: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of ex…
#JITC Research: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders https://t.co/vasRVZ50dT https://t.co/kXQCVgVEmT
RT @sitcancer: New #JITC Research: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates o…
New #JITC Research: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders https://t.co/vasRVZ50dT https://t.co/cDIAF3ANFU